{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:22:55Z","timestamp":1795040575903,"version":"4.10.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00134-024-07489-2","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T12:02:00Z","timestamp":1717416120000},"page":"1228-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre prospective cohort study"],"prefix":"10.1007","volume":"50","author":[{"given":"Toufik","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Janssen-Langenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Quelven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Pierre","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Bourenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Garot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fillatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Labruyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Heming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Lambiotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lesieur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Bachoumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Chalumeau-Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bougon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Guisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Coudroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4664-3661","authenticated-orcid":false,"given":"Thierry","family":"Boulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PCP-MULTI Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auchabie","family":"Johann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beuret","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darreau","family":"C\u00e9dric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmeulles","family":"Isabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guervilly","family":"Christophe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Tuan Ha","family":"Vivien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochmans","family":"S\u00e9bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozwiak","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navellou","family":"Jean-Christophe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neuville","family":"Mathilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichon","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagnier","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schnell","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"7489_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fpubh.2019.00275","volume":"7","author":"E Pereira-D\u00edaz","year":"2019","unstructured":"Pereira-D\u00edaz E, Moreno-Verdejo F, de la Horra C, Guerrero JA, Calder\u00f3n EJ, Medrano FJ (2019) Changing trends in the epidemiology and risk factors of pneumocystis pneumonia in Spain. Front Public Health 7:275. https:\/\/doi.org\/10.3389\/fpubh.2019.00275","journal-title":"Front Public Health"},{"key":"7489_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12879-021-06144-1","volume":"21","author":"S Gr\u00f8nseth","year":"2021","unstructured":"Gr\u00f8nseth S, Rogne T, Hannula R, \u00c5svold BO, Afset JE, Dam\u00e5s JK (2021) Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infect Dis 21:659. https:\/\/doi.org\/10.1186\/s12879-021-06144-1","journal-title":"BMC Infect Dis"},{"key":"7489_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100400","volume":"18","author":"B Kolbrink","year":"2022","unstructured":"Kolbrink B, Scheikholeslami-Sabzewari J, Borzikowsky C, von Samson- Himmelstjerna FA, Ullmann AJ, Kunzendorf U (2022) Schulte K (2022) Evolving epidemiology of pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany. Lancet Reg Health Eur 18:100400. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100400","journal-title":"Lancet Reg Health Eur"},{"key":"7489_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jinf.2023.02.014","volume":"86","author":"K Pates","year":"2023","unstructured":"Pates K, Periselneris J, Russell MD, Mehra V, Schelenz S, Galloway JB (2023) Rising incidence of Pneumocystis pneumonia: a population-level descriptive ecological study in England. J Infect 86:385\u2013390. https:\/\/doi.org\/10.1016\/j.jinf.2023.02.014","journal-title":"J Infect"},{"key":"7489_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","volume":"46","author":"A-L Bienvenu","year":"2016","unstructured":"Bienvenu A-L, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11\u201317","journal-title":"Int J Infect Dis"},{"key":"7489_CR6","doi-asserted-by":"publisher","first-page":"e0176881","DOI":"10.1371\/journal.pone.0176881","volume":"12","author":"A Ricciardi","year":"2017","unstructured":"Ricciardi A, Gentilotti E, Coppola L, Maffongelli G, Cerva C, Malagnino V et al (2017) Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: a retrospective analysis of 116 HIV positive and HIV-negative immunocompromised patients. PLoS ONE 12:e0176881","journal-title":"PLoS ONE"},{"key":"7489_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/14787210.2019.1671823","volume":"17","author":"C Cill\u00f3niz","year":"2019","unstructured":"Cill\u00f3niz C, Domined\u00f2 C, \u00c1lvarez-Mart\u00ednez MJ, Moreno A, Garc\u00eda F, Torres A, Miro JM (2019) Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther 17:787\u2013801. https:\/\/doi.org\/10.1080\/14787210.2019.1671823","journal-title":"Expert Rev Anti Infect Ther"},{"key":"7489_CR8","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3390\/ijerph19052768","volume":"19","author":"K Elango","year":"2022","unstructured":"Elango K, Mudgal M, Murthi S, Yella PR, Nagrecha S, Srinivasan V, Sekar V, Koshy M, Ramalingam S, Gunasekaran K (2022) Trends in the epidemiology and outcomes of pneumocystis pneumonia among human immunodeficiency virus (HIV) hospitalizations. Int J Environ Res Public Health 19:2768. https:\/\/doi.org\/10.3390\/ijerph19052768","journal-title":"Int J Environ Res Public Health"},{"key":"7489_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1378\/chest.128.2.573","volume":"128","author":"E Festic","year":"2005","unstructured":"Festic E, Gajic O, Limper AH, Aksamit TR (2005) Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 128:573\u2013579. https:\/\/doi.org\/10.1378\/chest.128.2.573","journal-title":"Chest"},{"key":"7489_CR10","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/cc6806","volume":"12","author":"X Monnet","year":"2008","unstructured":"Monnet X, Vidal-Petiot E, Osman D, Hamzaoui O, Durrbach A, Goujard C, Miceli C, Bour\u00e9e P, Richard C (2008) Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care 12:R28. https:\/\/doi.org\/10.1186\/cc6806","journal-title":"Crit Care"},{"key":"7489_CR11","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3201\/eid2009.131668","volume":"20","author":"A Roux","year":"2008","unstructured":"Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, Maubon D, Debourgogne A, Le Gal S, Dalle F, Leterrier M, Toubas D, Pomares C, Bellanger AP, Bonhomme J, Berry A, Durand-Joly I, Magne D, Pons D, Hennequin C, Maury E, Roux P, Azoulay \u00c9 (2008) Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis 20:1490\u20131497. https:\/\/doi.org\/10.3201\/eid2009.131668","journal-title":"Emerg Infect Dis"},{"key":"7489_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S (2018) Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care 22:307. https:\/\/doi.org\/10.1186\/s13054-018-2221-8","journal-title":"Crit Care"},{"key":"7489_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246296","volume":"16","author":"TO Kim","year":"2021","unstructured":"Kim TO, Lee JK, Kwon YS, Kim YI, Lim SC, Kim MS, Kho BG, Park CK, Oh IJ, Kim YC, Park HY, Shin HJ (2021) Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness. PLoS ONE 16:e0246296. https:\/\/doi.org\/10.1371\/journal.pone.0246296","journal-title":"PLoS ONE"},{"key":"7489_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10096-020-04118-w","volume":"40","author":"G Burghi","year":"2021","unstructured":"Burghi G, Biard L, Roux A, Valade S, Robert-Gangneux F, Hamane S, Maubon D, Debourgogne A, Le Gal S, Dalle F, Leterrier M, Toubas D, Pomares C, Bellanger AP, Bonhomme J, Berry A, Iriart X, Durand-Joly I, Magne D, Pons D, Hennequin C, Maury E, Azoulay E, Lemiale V (2021) Characteristics and outcome according to underlying disease in non-AIDS patients with acute respiratory failure due to Pneumocystis pneumonia. Eur J Clin Microbiol Infect Dis 40:1191\u20131198. https:\/\/doi.org\/10.1007\/s10096-020-04118-w","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7489_CR15","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.chest.2020.05.558","volume":"158","author":"A Ghembaza","year":"2020","unstructured":"Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D (2020) Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest 158:2323\u20132332. https:\/\/doi.org\/10.1016\/j.chest.2020.05.558","journal-title":"Chest"},{"key":"7489_CR16","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.semarthrit.2018.10.018","volume":"48","author":"G Schmajuk","year":"2019","unstructured":"Schmajuk G, Jafri K, Evans M, Shiboski S, Gianfrancesco M, Izadi Z, Patterson SL, Aggarwal I, Sarkar U, Dudley RA, Yazdany J (2019) Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. Semin Arthritis Rheum 48:1087\u20131092. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.10.018","journal-title":"Semin Arthritis Rheum"},{"key":"7489_CR17","doi-asserted-by":"publisher","first-page":"ofz315","DOI":"10.1093\/ofid\/ofz315","volume":"6","author":"RM Wolfe","year":"2019","unstructured":"Wolfe RM, Beekmann SE, Polgreen PM, Winthrop KL, Peacock JE Jr (2019) Practice patterns of pneumocystis pneumonia prophylaxis in connective tissue diseases: a survey of infectious disease physicians. Open Forum Infect Dis 6:ofz315. https:\/\/doi.org\/10.1093\/ofid\/ofz315","journal-title":"Open Forum Infect Dis"},{"key":"7489_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/ecco-jcc\/jjac153","volume":"17","author":"S Vieujean","year":"2023","unstructured":"Vieujean S, Moens A, Hassid D, Rothfuss K, Savarino EV, Vavricka SR, Reenaers C, Jacobsen BA, Allez M, Ferrante M, Rahier JF (2023) Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease\u2014a case series. J Crohns Colitis 17:472\u2013479. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac153","journal-title":"J Crohns Colitis"},{"key":"7489_CR19","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/phar.2733","volume":"42","author":"CM Sierra","year":"2022","unstructured":"Sierra CM, Daiya KC (2022) Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: a systematic review. Pharmacotherapy 42:858\u2013867. https:\/\/doi.org\/10.1002\/phar.2733","journal-title":"Pharmacotherapy"},{"key":"7489_CR20","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","volume":"22","author":"RB Weyant","year":"2021","unstructured":"Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C (2021) Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother 22:1579\u20131592. https:\/\/doi.org\/10.1080\/14656566.2021.1915989","journal-title":"Expert Opin Pharmacother"},{"key":"7489_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/17476348.2022.2152332","volume":"16","author":"AR Alsayed","year":"2022","unstructured":"Alsayed AR, Al-Dulaimi A, Alkhatib M, Al Maqbali M, Al-Najjar MAA, Al- Rshaidat MMD (2022) A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients. Expert Rev Respir Med 16:1167\u20131190. https:\/\/doi.org\/10.1080\/17476348.2022.2152332","journal-title":"Expert Rev Respir Med"},{"key":"7489_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002726","volume":"8","author":"GE Fragoulis","year":"2022","unstructured":"Fragoulis GE, Dey M, Zhao S, Schoones J, Courvoisier D, Galloway J, Hyrich KL, Nikiphorou E (2022) Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. RMD Open 8:e002726. https:\/\/doi.org\/10.1136\/rmdopen-2022-002726","journal-title":"RMD Open"},{"key":"7489_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jama.2023.9844","volume":"330","author":"S Zhou","year":"2023","unstructured":"Zhou S, Aitken SL (2023) Prophylaxis against Pneumocystis jirovecii pneumonia in adults. JAMA 330:182\u2013183. https:\/\/doi.org\/10.1001\/jama.2023.9844","journal-title":"JAMA"},{"key":"7489_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","volume":"47","author":"MC Li","year":"2014","unstructured":"Li MC, Lee NY, Lee CC, Lee HC, Chang CM, Ko WC (2014) Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect 47:42\u201347. https:\/\/doi.org\/10.1016\/j.jmii.2012.08.024","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"7489_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.revmed.2015.10.002","volume":"37","author":"P Fill\u00e2tre","year":"2016","unstructured":"Fill\u00e2tre P, Revest M, Belaz S, Robert-Gangneux F, Zahar JR, Roblot F, Tattevin P (2016) Pneumocystose chez les patients immunod\u00e9prim\u00e9s non infect\u00e9s par le VIH [Pneumocystosis in non-HIV-infected immunocompromised patients]. Rev Med Interne 37(5):327\u2013336. https:\/\/doi.org\/10.1016\/j.revmed.2015.10.002","journal-title":"Rev Med Interne"},{"key":"7489_CR26","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","volume":"158","author":"JA Ramirez","year":"2020","unstructured":"Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA et al (2020) Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies. Chest 158:1896\u20131911. https:\/\/doi.org\/10.1016\/j.chest.2020.05.598","journal-title":"Chest"},{"key":"7489_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","volume":"100","author":"JA Kovacs","year":"1984","unstructured":"Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane HC, Urmacher C, Honig C, Longo DL et al (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663\u2013671. https:\/\/doi.org\/10.7326\/0003-4819-100-5-663","journal-title":"Ann Intern Med"},{"key":"7489_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s10156-012-0441-4","volume":"18","author":"N Asai","year":"2012","unstructured":"Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakashima K, Iwasaki T, Nakashita T, Otsuka Y, Kaneko N (2012) Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection. J Infect Chemother 18:898\u2013905. https:\/\/doi.org\/10.1007\/s10156-012-0441-4","journal-title":"J Infect Chemother"},{"key":"7489_CR29","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1186\/s12879-022-07940-z","volume":"22","author":"S Song","year":"2022","unstructured":"Song S, Zhang Y, Yu J, Xie C, Chen Y, Zhang X (2022) Time to trimethoprim\/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality. BMC Infect Dis 22:961. https:\/\/doi.org\/10.1186\/s12879-022-07940-z","journal-title":"BMC Infect Dis"},{"issue":"4","key":"7489_CR30","doi-asserted-by":"publisher","first-page":"006150","DOI":"10.1002\/14651858.CD006150","volume":"2015","author":"H Ewald","year":"2015","unstructured":"Ewald H, Raatz H, Boscacci R, Furrer H, Bucher HC, Briel M (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev 2015(4):006150. https:\/\/doi.org\/10.1002\/14651858.CD006150","journal-title":"Cochrane Database Syst Rev"},{"key":"7489_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arbres.2016.06.016","volume":"53","author":"Y Fujikura","year":"2017","unstructured":"Fujikura Y, Manabe T, Kawana A, Kohno S (2017) Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV infected patients: a systematic review and meta-analysis of observational studies. Arch Bronconeumol 53:55\u201361. https:\/\/doi.org\/10.1016\/j.arbres.2016.06.016","journal-title":"Arch Bronconeumol"},{"key":"7489_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","volume":"154","author":"PM Wieruszewski","year":"2018","unstructured":"Wieruszewski PM, Barreto JN, Frazee E, Daniels CE, Tosh PK, Dierkhising RA, Mara KC, Limper AH (2018) Early corticosteroids for pneumocystis pneumonia in adults without HIV are not associated with better outcome. Chest 154:636\u2013644. https:\/\/doi.org\/10.1016\/j.chest.2018.04.026","journal-title":"Chest"},{"key":"7489_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2018.12.001","volume":"79","author":"N Inoue","year":"2019","unstructured":"Inoue N, Fushimi K (2019) Adjunctive corticosteroids decreased the risk of mortality of non-HIV pneumocystis pneumonia. Int J Infect Dis 79:109\u2013115. https:\/\/doi.org\/10.1016\/j.ijid.2018.12.001","journal-title":"Int J Infect Dis"},{"issue":"4","key":"7489_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250611","volume":"16","author":"M Assal","year":"2021","unstructured":"Assal M, Lambert J, Chow-Chine L, Bisbal M, Servan L, Gonzalez F, de Guibert JM, Faucher M, Vey N, Sannini A, Mokart D (2021) Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: a propensity score analysis. PLoS ONE 16(4):e0250611. https:\/\/doi.org\/10.1371\/journal.pone.0250611","journal-title":"PLoS ONE"},{"issue":"23","key":"7489_CR35","doi-asserted-by":"publisher","first-page":"00858","DOI":"10.1016\/j.ajt.2023.11.003","volume":"S1600\u20136135","author":"SM Hosseini-Moghaddam","year":"2023","unstructured":"Hosseini-Moghaddam SM, Kothari S, Humar A, Albasata H, Yetmar ZA, Razonable RR, Neofytos D, D\u2019Asaro M, Boggian K, Hirzel C, Khanna N, Manuel O, Mueller NJ, Imlay H, Kabbani D, Tyagi V, Smibert OC, Nasra M, Fontana L, Obeid KM, Apostolopoulou A, Zhang SX, Permpalung N, Alhatimi H, Silverman MS, Guo H, Rogers BA, MacKenzie E, Pisano J, Gioia F, Rapi L, Prasad GVR, Banegas M, Alonso CD, Doss K, Rakita RM, Fishman JA (2023) Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a multicenter cohort, 2015\u20132020. Am J Transpl S1600\u20136135(23):00858\u201300864. https:\/\/doi.org\/10.1016\/j.ajt.2023.11.003","journal-title":"Am J Transpl"},{"issue":"Suppl 2","key":"7489_CR36","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1093\/cid\/ciaa1805","volume":"72","author":"K Lagrou","year":"2021","unstructured":"Lagrou K, Chen S, Masur H, Viscoli C, Decker CF, Pagano L, Groll AH (2021) Pneumocystis jirovecii disease: basis for the revised EORTC\/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus. Clin Infect Dis 72(Suppl 2):S114\u2013S120. https:\/\/doi.org\/10.1093\/cid\/ciaa1805","journal-title":"Clin Infect Dis"},{"key":"7489_CR37","doi-asserted-by":"publisher","first-page":"W555","DOI":"10.2214\/AJR.11.7329","volume":"198","author":"JP Kanne","year":"2012","unstructured":"Kanne JP, Yandow DR, Meyer CA (2012) Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection. AJR Am J Roentgenol 198:W555-561","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"7489_CR38","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1128\/JCM.03174-15","volume":"54","author":"T Fauchier","year":"2016","unstructured":"Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C (2016) Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV positive and HIV-negative patients. J Clin Microbiol 54(6):1487\u20131495. https:\/\/doi.org\/10.1128\/JCM.03174-15","journal-title":"J Clin Microbiol"},{"key":"7489_CR39","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/sim.4780111409","volume":"11","author":"LJ Wei","year":"1992","unstructured":"Wei LJ (1992) The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Stat Med 11:1871\u20131879","journal-title":"Stat Med"},{"key":"7489_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5657","volume":"367","author":"RJ Desai","year":"2019","unstructured":"Desai RJ, Franklin JM (2019) Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners. BMJ 367:l5657. https:\/\/doi.org\/10.1136\/bmj.l5657","journal-title":"BMJ"},{"key":"7489_CR41","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.270.24.2957","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 270:2957\u20132963. https:\/\/doi.org\/10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"7489_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707\u2013710. https:\/\/doi.org\/10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"key":"7489_CR43","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/aje\/kwab041","volume":"190","author":"T St\u00fcrmer","year":"2021","unstructured":"St\u00fcrmer T, Webster-Clark M, Lund JL, Wyss R, Ellis AR, Lunt M, Rothman KJ, Glynn RJ (2021) Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study. Am J Epidemiol 190:1659\u20131670. https:\/\/doi.org\/10.1093\/aje\/kwab041","journal-title":"Am J Epidemiol"},{"key":"7489_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1258\/ijsa.2009.009107","volume":"20","author":"F Bruneel","year":"2009","unstructured":"Bruneel F, Veziris N, Chevret S, Wolff M, Bedos JP (2009) Retrospective review of Pneumocystis jirovecii pneumonia in a French intensive care unit (1994\u20132000). Int J STD AIDS 20:441\u2013442. https:\/\/doi.org\/10.1258\/ijsa.2009.009107","journal-title":"Int J STD AIDS"},{"issue":"1","key":"7489_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1465-9921-14-87","volume":"14","author":"V Lemiale","year":"2013","unstructured":"Lemiale V, Debrumetz A, Delannoy A, Alberti C, Azoulay E (2013) Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia. Respir Res 14(1):87. https:\/\/doi.org\/10.1186\/1465-9921-14-87","journal-title":"Respir Res"},{"key":"7489_CR46","doi-asserted-by":"publisher","unstructured":"- Giacobbe DR, Dettori S, Di Pilato V, Asperges E, Ball L, Berti E, et al; JIR-ICU investigators (collaborators); Critically Ill Patients Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG) (2023) Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Crit Care 27:323. https:\/\/doi.org\/10.1186\/s13054-023-04608-1","DOI":"10.1186\/s13054-023-04608-1"},{"key":"7489_CR47","first-page":"2526","volume":"307","author":"ARDS Definition Task Force","year":"2012","unstructured":"Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526\u20132533","journal-title":"JAMA"},{"key":"7489_CR48","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/myc.12997","volume":"62","author":"G Desoubeaux","year":"2019","unstructured":"Desoubeaux G, Chesnay A, Mercier V, Bras-Cachinho J, Moshiri P, Eymieux S, De Kyvon MA, Lemaignen A, Goudeau A, Bailly \u00c9 (2019) Combination of \u03b2-(1, 3)-D-glucan testing in serum and qPCR in nasopharyngeal aspirate for facilitated diagnosis of Pneumocystis jirovecii pneumonia. Mycoses 62:1015\u20131022. https:\/\/doi.org\/10.1111\/myc.12997","journal-title":"Mycoses"},{"key":"7489_CR49","first-page":"604","volume":"50","author":"RB Wettstein","year":"2005","unstructured":"Wettstein RB, Shelledy DC, Peters JI (2005) Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care 50:604\u2013609","journal-title":"Respir Care"},{"key":"7489_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1183\/09031936.00010206","volume":"29","author":"JM Boles","year":"2007","unstructured":"Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T (2007) Weaning from mechanical ventilation. Eur Respir J 29:1033\u20131056. https:\/\/doi.org\/10.1183\/09031936.00010206","journal-title":"Eur Respir J"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07489-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:18:35Z","timestamp":1723011515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7489"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07489-2","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no competing interests for any author concerning the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study adhered to French legal regulations for prospective non-interventional studies and was conducted in accordance with the Declaration of Helsinki and its later amendments. Patients and families received both verbal and written information about the study upon patient eligibility, with the option to consent or decline participation. The study protocol received approval from the ethics committee of the French Intensive Care Society on May 20, 2020 (#CE SRLF 20-48).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}